COZZOLI, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 1.427
EU - Europa 704
AS - Asia 268
Continente sconosciuto - Info sul continente non disponibili 3
SA - Sud America 1
Totale 2.403
Nazione #
US - Stati Uniti d'America 1.416
PL - Polonia 199
DE - Germania 167
CN - Cina 166
UA - Ucraina 147
HK - Hong Kong 56
FI - Finlandia 50
FR - Francia 30
IT - Italia 29
IE - Irlanda 26
GB - Regno Unito 25
RU - Federazione Russa 21
IN - India 15
VN - Vietnam 14
CA - Canada 10
TR - Turchia 6
SE - Svezia 5
EU - Europa 3
IR - Iran 3
AT - Austria 2
SG - Singapore 2
AE - Emirati Arabi Uniti 1
AR - Argentina 1
ES - Italia 1
HU - Ungheria 1
ID - Indonesia 1
IL - Israele 1
JM - Giamaica 1
MY - Malesia 1
NL - Olanda 1
NP - Nepal 1
OM - Oman 1
Totale 2.403
Città #
Warsaw 199
Fairfield 198
Woodbridge 189
Ashburn 142
Jacksonville 117
Houston 90
Cambridge 76
New York 71
Seattle 69
Wilmington 66
Dearborn 65
Hong Kong 56
Chandler 55
Princeton 54
Ann Arbor 49
Helsinki 38
Beijing 36
Dublin 26
Nanjing 22
Dong Ket 14
Jinan 14
Changsha 13
Des Moines 12
Los Angeles 10
Nürnberg 10
Toronto 10
Hefei 9
San Diego 9
San Mateo 9
Lancaster 8
Shenyang 8
Shanghai 7
Washington 7
Monmouth Junction 6
Taizhou 6
Tianjin 6
Zhengzhou 6
Hebei 5
Kunming 5
Augusta 4
Brescia 4
Frankfurt am Main 4
Jiaxing 4
Nanchang 4
Tavernola Bergamasca 4
Ardabil 3
Hangzhou 3
Lanzhou 3
Prescot 3
Verona 3
Changchun 2
Fuzhou 2
Guangzhou 2
Islington 2
Kocaeli 2
Leawood 2
London 2
Milan 2
Ningbo 2
Norwalk 2
Boardman 1
Budapest 1
Buenos Aires 1
Caravate 1
Carmignano 1
Chiswick 1
Falkenstein 1
Gunzenhausen 1
Haifa 1
Haikou 1
Hanover 1
Kalininskiy 1
Kilburn 1
Lincoln 1
Mumbai 1
Murcia 1
Muscat 1
New Delhi 1
Orange 1
Pune 1
Quzhou 1
Redwood City 1
San Francisco 1
Swindon 1
Taiyuan 1
Tappahannock 1
Tempio Pausania 1
Venezia 1
Wandsworth 1
Wenzhou 1
Ürümqi 1
Totale 1.882
Nome #
Positive Surgical Margins Predict Progression-free Survival After Nephron-sparing Surgery for Renal Cell Carcinoma: Results From a Single Center Cohort of 459 Cases With a Minimum Follow-up of 5 Years 141
DISCRIMINATION ABILITY OF THE SURFACE-INTERMEDIATE-BASE MARGIN (SIB) SCORE: AN EXTERNAL HISTOPATHOLOGICAL EVALUATION 134
PATHOGENESIS, FEATURES AND PROGNOSIS OF RENAL RELAPSE AFTER PARTIAL NEPHRECTOMY 120
Venous tumor thrombus consistency is not predictive of survival in patients with renal cell carcinoma: A retrospective study of 147 patients 119
Long-term Prognostic Impact of Chromosome Abnormalities in Clear Cell Renal Cell Carcinoma 119
Features of Ipsilateral Renal Recurrences After Partial Nephrectomy: A Proposal of a Pathogenetic Classification 118
PATHOGENESIS, FEATURES AND PROGNOSIS OF RENAL RELAPSE AFTER PARTIAL NEPHRECTOMY 118
Renal Function Impairment Below Safety Limits Correlates With Cancer-specific Mortality in Localized Renal Cell Carcinoma: Results From a Single-center Study 111
Features, risk factors and clinical outcome of "very late" recurrences after surgery for localized renal carcinoma: A retrospective evaluation of a cohort with a minimum of 10 years of follow up 108
Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients 107
VENOUS TUMOR THROMBUS CONSISTENCY IS NOT PREDICTIVE OF SURVIVAL IN PATIENTS WITH RENAL CELL CARCINOMA: A RETROSPECTIVE STUDY ON 147 PATIENTS 105
Holographic Reconstructions for Preoperative Planning before Partial Nephrectomy: A Head-to-Head Comparison with Standard CT Scan 98
The follow-up management of non-metastatic renal cell carcinoma: Definition of a surveillance protocol 98
Surgical treatment of adrenal metastasis from renal cell carcinoma: A single-centre experience of 45 patients 95
DISCRIMINATION ABILITY OF TH SURFACE-INTERMEDIATE-BASE MARGIN :(SIB) SCORE: AN EXTERNAL HISTOPATHOLOGICAL EVALUATION 91
Nephron-Sparing Surgery versus Radical Nephrectomy in the Treatment of Intracapsular Renal Cell Carcinoma up to 7 cm 91
HOW LONG SHOULD BE EXTENDED FOLLOW UP AFTER SURGERY FOR RENAL CANCER? RETROSPECTIVE ANALYSIS OF A COHORT OF PATIENTS WITH MORE THAN 10 YEARS OF FOLLOW UP 86
[T&G: an elementary integrated prognostic system for renal carcinoma N0 M0]. 84
Clinical features and prognosis of patients with renal cancer and a second malignancy 78
HOW LONG SHOULD BE EXTENDED FOLLOW UP AFTER SURGERY FOR RENAL CANCER? RETROSPECTIVE ANALYSIS OF A COHORT OF PATIENTS WITH MORE THAN 10 YEARS OF FOLLOW UP 77
HOW LONG SHOULD THE FOLLOW-UP BE EXTENDED AFTER SURGERY FOR RENAL CANCER? RETROSPECTIVE ANALYSIS OF A COHORT OF PATIENTS WITH MORE THAN 10 YEARS OF FOLLOW-UP 76
AGE IS THE MAIN PREDICTOR OF COMPLICATIONS AFTER SURGERY FOR RENAL TUMOR: SYSTEMATIC EVALUATION OF 1800 PATIENTS IN A SINGLE-CENTRE COHORT 66
Renal cell carcinoma: A long natural history in a young patient 66
External Validation of the Arterial-Based Complexity Score and First Head-to-Head Comparison With the R.E.N.A.L. and PADUA Scores and C-index 58
Second surgery for renal relapse after nephron sparing surgery: Review of seven cases 38
Prognostic value of cytogenetic analysis in clear cell renal carcinoma: A study on 131 patients with long-term follow-up 35
Clinical approach 34
Totale 2.471
Categoria #
all - tutte 9.389
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.389


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201987 0 0 0 0 0 0 0 0 0 0 49 38
2019/2020733 77 18 20 47 34 95 73 72 67 135 49 46
2020/2021540 26 42 47 77 24 58 20 59 43 64 44 36
2021/2022231 26 43 5 7 0 8 15 10 11 35 16 55
2022/2023173 28 2 10 1 14 46 0 18 28 0 13 13
2023/2024297 18 5 20 41 24 103 3 14 59 10 0 0
Totale 2.471